Company · CIK 1830749
Achilles Therapeutics plc
| CIK | 1830749 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | X0 |
| Business address | United Kingdom |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2022-03-01 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-268239 | 2022-11-08 | 2025-03-11 | 3 | |
| 333-253735 | 2021-03-01 | 2021-03-31 | 6 |
Filings
10| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-03-11 | EFFECTDeclared effective | 333-268239 | 9999999995-25-000635 |
| 2022-11-17 | EFFECTDeclared effective | 333-268239 | 9999999995-22-003336 |
| 2022-11-08 | F-3Shelf registered | 333-268239 | 0001193125-22-279779 |
| 2021-03-31 | 424B4Final prospectus | 333-253735 | 0001193125-21-102495 |
| 2021-03-30 | EFFECTDeclared effective | 333-253735 | 9999999995-21-001207 |
| 2021-03-29 | F-1/AAmendment | 333-253735 | 0001193125-21-098251 |
| 2021-03-25 | F-1/AAmendment | 333-253735 | 0001193125-21-093358 |
| 2021-03-10 | F-1/AAmendment | 333-253735 | 0001193125-21-076206 |
| 2021-03-01 | F-1Registration filed | 333-253735 | 0001193125-21-063774 |
| 2020-11-27 | DRSDraft made public | 377-03834 | 0000950123-20-012393 |